Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel— 510(k) K241806

Substantially Equivalent

Life Technologies Corporation

FDA 510(k) clearance K241806 for Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel, Substantially Equivalent on 2025-01-08. Applicant: Life Technologies Corporation.

Clearance details

Applicant
Life Technologies Corporation
Product code
Code QOF
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Pleasanton,, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.